Latest News about BMY
Recent news which mentions BMY
Bristol Myers Squibb Takes On Novartis, Eli Lilly With RayzeBio $4B Deal In Radiopharmaceuticals
December 26, 2023
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
December 25, 2023
From Benzinga
From Motley Fool
Dow Edges Lower; Nike Sales Miss Estimates
December 22, 2023
From Benzinga
Why AAR Shares Are Trading Lower By 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
December 22, 2023
From Benzinga
HBM Gets Health Boost From Drug Licensing Deals
December 22, 2023
From Benzinga
S&P 500, Nasdaq 100 Aim For 8th Week Of Gains As Fed's Inflation Gauge Cools: What's Driving Markets Friday?
December 22, 2023
From Benzinga
Gold Moves Higher; US Consumer Sentiment Improves In December
December 22, 2023
From Benzinga
With Karuna Therapeutics $14B Deal, Bristol Myers Is Serious For Re-Establishing Its Neurology Portfolio: Analyst
December 22, 2023
From Benzinga
Karuna Therapeutics Jumps Following Takeover By Bristol Myers, Joins Rocket Lab USA, Altair Engineering And Other Big Stocks Moving Higher On Friday
December 22, 2023
From Benzinga
Health Care Company Bristol-Myers Squibb Announces Merger With Karuna Therapeutics
December 22, 2023
From Benzinga
Dow Rises 50 Points; Fed's Preferred Inflation Gauge Cools In November
December 22, 2023
From Benzinga
Bristol Myers Squibb Scoops Up Schizophrenia Player Karuna Therapeutics In Massive $14B Deal
December 22, 2023
From Benzinga
3 Potential Turnaround Stocks to Buy for Big Rewards in 2024
December 20, 2023
From InvestorPlace
Better Dividend Stock: Bristol Myers Squibb or Merck?
December 19, 2023
From Motley Fool
Jim Cramer Slams FTC Chair Lina Khan's Policies For Hampering Investor Returns: 'One-Woman Wrecking Crew For Your Stock Portfolio'
December 18, 2023
From Benzinga
7 Stocks with Strong Insider Buying: December 2023
December 17, 2023
From InvestorPlace
A Closer Look at Bristol-Myers Squibb's Options Market Dynamics
December 15, 2023
Tickers
BMY
From Benzinga
From Benzinga
This 1 Emerging Risk Could Be a Problem for These 3 Big Pharma Stocks
December 10, 2023
From Motley Fool
3 Dividend Stocks Trading at 52-Week Lows
December 09, 2023
From Motley Fool
Insiders Buying Bristol-Myers Squibb And 3 Other Stocks
December 08, 2023
From Benzinga
From Benzinga
2024's Potential Stock Surprises: Goldman Sachs Unveils S&P 500 Laggards For Major Gains
December 06, 2023
From Benzinga
3 Dirt-Cheap Stocks That Could Skyrocket
December 05, 2023
From Motley Fool
Eyes On Novartis, Gilead, Bristol Myers As FDA Weighs Risks Vs. Benefits Of Approved CAR T-Cell Therapies
November 29, 2023
From Benzinga
Cabaletta Bio’s and Gracell’s stock falls sharply as FDA investigates risks of CAR-T therapy
November 28, 2023
From MarketWatch
Why Is Avidity Biosciences (RNA) Stock Up 15% Today?
November 28, 2023
From InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
More ways to get to us
Facebook
Twitter
YouTubeContact the Lethbridge Herald
504 - 7th Street South
Lethbridge, AB T1J 3Z7
[P] (403) 328-4411
[F] (403)328-4536
Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433
© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.